4.7 Article

Widespread white matter microstructural abnormalities in bipolar disorder: evidence from mega- and meta-analyses across 3033 individuals

期刊

NEUROPSYCHOPHARMACOLOGY
卷 44, 期 13, 页码 2285-2293

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41386-019-0485-6

关键词

-

资金

  1. German Research Foundation (DFG) [FOR2107 DA1151/5-1, DA1151/5-2, SFB-TRR58]
  2. Interdisciplinary Center for Clinical Research (IZKF) of the medical faculty of Munster [Dan3/012/17]
  3. German Research Foundation [SFB636/C6, WE3638/3-1]
  4. VA Desert-Pacific Mental Illness Research Education and Clinical Center
  5. Research Council of Norway [223273, 213837, 249711, 249795, 248238, 248778, 262656]
  6. NIH [MH083968]
  7. South East Norway Health Authority [2017-112]
  8. Kristian Gerhard Jebsen Stiftelsen [SKGJ-MED-008]
  9. European Community's Seventh Framework Program (FP7/2007-2013) [602450]
  10. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil) [480370/2009-5]
  11. Australian National Medical and Health Research Council [1037196]
  12. Lansdowne Foundation
  13. NIH from the BD2K Initiative [U54 EB020403, R01 MH116147, P41 EB015922]
  14. CIBERSAM
  15. NHG [SIG/12004]
  16. SBIC [RP C-009]
  17. SAMRC
  18. Canadian Institutes of Health Research [103703, 106469, 64410]
  19. Nova Scotia Health Research Foundation, Dalhousie Clinical Research and Scholarship
  20. NARSAD Young Investigator and Independent Investigator Awards
  21. JMAS SIM fellowship from the Royal College of Physicians of Edinburgh
  22. ESAT College Fellowship from the University of Edinburgh
  23. NARSAD Young Investigator Award [17319]
  24. Spanish Ministry of Science, Innovation and Universities [PI15/00283]
  25. Comissionat per a Universitats i Recerca del DIUE de la Generalitat de Catalunya [2017 SGR 1365]
  26. PERIS 2016-2020 (Departament de Salut) [SLT006/17/00357]
  27. CERCA Programme/Generalitat de Catalunya
  28. FAPESP-Brazil [2009/14891-9, 2010/18672-7, 2012/23796-2, 2013/03905-4]
  29. CNPqBrazil [478466/2009, 480370/2009]
  30. Wellcome Trust (UK)
  31. Brain & Behavior Research Foundation (NARSAD Independent Investigator Award)
  32. NIA [T32AG058507]
  33. NIH/NIMH [5T32MH073526]
  34. NIH from the Big Data to Knowledge (BD2K) Program [U54EB020403]
  35. Human Brain Project - European Union's Horizon 2020 Framework Program for Research and Innovation [785907, 604102]
  36. FRM [DIC20161236445]
  37. French program Investissement d'Avenir by the Agence Nationale pour la Recherche
  38. grant Infrastructure d'avenir en Biologie Sante [ANR-11-INBS-0006]
  39. Agence Nationale pour la Recherche [ANR-11-IDEX-0004 Labex BioPsy, ANR-10-COHO-10-01 psyCOH]
  40. Fondation pour la Recherche Medicale (Bioinformatique pour la biologie 2014)
  41. Fondation de l'Avenir (Recherche Medicale Appliquee 2014)
  42. AB-Biotics
  43. Abbott
  44. Allergan
  45. Angelini
  46. Dainippon Sumitomo Pharma
  47. Galenica
  48. Janssen
  49. Lundbeck
  50. Novartis
  51. Otsuka
  52. Sage
  53. Sanofi-Aventis
  54. Takeda
  55. Oslo University Hospital
  56. University of Oslo
  57. Norwegian Research Council
  58. South Eastern Norwegian Health Authorities
  59. ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER), CIBERSAM
  60. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [10/18672-7, 09/14891-9] Funding Source: FAPESP

向作者/读者索取更多资源

Fronto-limbic white matter (WM) abnormalities are assumed to lie at the heart of the pathophysiology of bipolar disorder (BD); however, diffusion tensor imaging (DTI) studies have reported heterogeneous results and it is not clear how the clinical heterogeneity is related to the observed differences. This study aimed to identify WM abnormalities that differentiate patients with BD from healthy controls (HC) in the largest DTI dataset of patients with BD to date, collected via the ENIGMA network. We gathered individual tensor-derived regional metrics from 26 cohorts leading to a sample size of N = 3033 (1482 BD and 1551 HC). Mean fractional anisotropy (FA) from 43 regions of interest (ROI) and average whole-brain FA were entered into univariate mega- and meta-analyses to differentiate patients with BD from HC. Mega-analysis revealed significantly lower FA in patients with BD compared with HC in 29 regions, with the highest effect sizes observed within the corpus callosum (R-2 = 0.041, P-corr < 0.001) and cingulum (right: R-2 = 0.041, left: R-2 = 0.040, P-corr < 0.001). Lithium medication, later onset and short disease duration were related to higher FA along multiple ROIs. Results of the meta-analysis showed similar effects. We demonstrated widespread WM abnormalities in BD and highlighted that altered WM connectivity within the corpus callosum and the cingulum are strongly associated with BD. These brain abnormalities could represent a biomarker for use in the diagnosis of BD. Interactive three-dimensional visualization of the results is available at www.enigma-viewer.org.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据